Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Non-invasive combined surrogates of remifentanil blood concentrations with relevance to analgesia.

Lötsch J, Skarke C, Darimont J, Zimmermann M, Bräutigam L, Geisslinger G, Ultsch A, Oertel BG.

Naunyn Schmiedebergs Arch Pharmacol. 2013 Oct;386(10):865-73. doi: 10.1007/s00210-013-0889-5. Epub 2013 Jun 18.

PMID:
23775505
2.

Regional distribution of solute carrier mRNA expression along the human intestinal tract.

Meier Y, Eloranta JJ, Darimont J, Ismair MG, Hiller C, Fried M, Kullak-Ublick GA, Vavricka SR.

Drug Metab Dispos. 2007 Apr;35(4):590-4. Epub 2007 Jan 12.

PMID:
17220238
3.

Comparison of two screening methods for in-house genotyping in clinical pharmacology units.

Darimont J, Grösch S, Skarke C, Geisslinger G, Lötsch J.

Int J Clin Pharmacol Ther. 2005 Jan;43(1):17-22.

PMID:
15704610
4.

Pharmacokinetics of morphine are not altered in subjects with Gilbert's syndrome.

Skarke C, Schmidt H, Geisslinger G, Darimont J, Lötsch J.

Br J Clin Pharmacol. 2003 Aug;56(2):228-31.

5.

Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers.

Skarke C, Darimont J, Schmidt H, Geisslinger G, Lötsch J.

Clin Pharmacol Ther. 2003 Jan;73(1):107-21.

PMID:
12545149
6.

Does the A118G polymorphism at the mu-opioid receptor gene protect against morphine-6-glucuronide toxicity?

Lötsch J, Zimmermann M, Darimont J, Marx C, Dudziak R, Skarke C, Geisslinger G.

Anesthesiology. 2002 Oct;97(4):814-9.

PMID:
12357145
7.

The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine.

Lötsch J, Skarke C, Grösch S, Darimont J, Schmidt H, Geisslinger G.

Pharmacogenetics. 2002 Jan;12(1):3-9.

PMID:
11773859
8.

Effects of the opioid remifentanil on olfactory function in healthy volunteers.

Lötsch J, Darimont J, Skarke C, Zimmermann M, Hummel T, Geisslinger G.

Life Sci. 2001 Sep 28;69(19):2279-85.

PMID:
11669470
9.

[Intestinal flora in the neonate: impact on morbidity and therapeutic perspectives].

Langhendries JP, Paquay T, Hannon M, Darimont J.

Arch Pediatr. 1998 Jun;5(6):644-53. Review. French.

PMID:
9759211
10.

Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit.

Langhendries JP, Battisti O, Bertrand JM, François A, Kalenga M, Darimont J, Scalais E, Wallemacq P.

Biol Neonate. 1998 Nov;74(5):351-62.

PMID:
9742264
11.

Effect of a fermented infant formula containing viable bifidobacteria on the fecal flora composition and pH of healthy full-term infants.

Langhendries JP, Detry J, Van Hees J, Lamboray JM, Darimont J, Mozin MJ, Secretin MC, Senterre J.

J Pediatr Gastroenterol Nutr. 1995 Aug;21(2):177-81.

PMID:
7472904
12.

Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity.

Langhendries JP, Battisti O, Bertrand JM, François A, Darimont J, Ibrahim S, Tulkens PM, Bernard A, Buchet JP, Scalais E.

Dev Pharmacol Ther. 1993;20(3-4):220-30.

PMID:
7828457

Supplemental Content

Loading ...
Support Center